$CYAB

CYABRA, INC. (CYAB): Entry into a Material Definitive Agreement

CYABRA, INC. (CYAB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 7 ea029760001ex10-1.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “ Agreement ”) is dated as of July 9, 2026, between Cyabra, Inc., a Delaware corporation (the “ Company ”), and each purchaser

Original reporting
Published Jul 10, 2026, 8:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 8:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CYAB
Neutral
medium confidence
Mentioned
$CYAB
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CYABNeutralMed
01

Why it matters

This type of disclosure typically corresponds to a private placement or similar financing. The key trading question is whether the terms imply meaningful dilution or warrant overhang versus a manageable capital need.

02

Market read

A new financing agreement can change the stock’s risk profile immediately, especially if pricing and warrant coverage are unfavorable.

03

What to watch

Traders should verify the final transaction size, subscription amount, conversion/warrant terms, and any resale-registration or lock-up provisions, which are not included in the excerpt.

Relevance 6/10Novelty 6/10Timing: Filed after-hours on 2026-07-10, ahead of the next trading session.

Background

The filing is an SEC Form 8-K (Item 1.01 and Item 3.02) describing entry into a material definitive agreement and unregistered sales of equity securities via a securities purchase agreement dated July 9, 2026.

Company-level read

Ticker impact

$CYABNeutralMedium confidence
Context

Cyabra, Inc. filed an 8-K stating it entered a material definitive agreement and a securities purchase agreement for unregistered equity sales.

Expected impact

Near-term downside bias is possible if the deal is dilutive or priced below market, but direction depends on the final purchase price, size, and warrant terms not shown in the excerpt.

Evidence & confidence

The article is an SEC 8-K for a securities purchase agreement, but the provided body excerpt is largely boilerplate definitions and does not include key deal economics (amount, price, discount, warrant coverage).

Market effects

Limited sector read-through; this is company-specific capital-raise mechanics rather than an industry-wide catalyst.

No clear regional spillover indicated by the excerpt.

No global macro or cross-border transaction details provided.

Counterpoint

If the financing is small, priced at a premium, or structured with limited dilution, the market reaction could be muted or even positive.

Key entities

  • Cyabra, Inc.

    Subject of the 8-K, entering a securities purchase agreement and disclosing unregistered equity sales.

  • Securities Purchase Agreement (Exhibit 10.1)

    Defines the transaction framework for issuance and sale of securities to purchasers under Regulation D and/or Section 4(a)(2).

Related articles

$CYABMedAI 8/10

Cyabra Delivers Record Second Quarter Revenue with 39% Year-Over-Year Growth

Cyabra, Inc. (Nasdaq: CYAB) reported record Q2 2026 revenue of $1.9 million, up 39% year over year from $1.3 million, driven mainly by new customer wins and higher existing-customer revenue. Gross margin stayed about 84%. The company also cited a $500,000+ research institute agreement, new government and intelligence customers, and a $6.0 million private placement.

$CYABMedAI 8/10

Cyabra Announces Pricing of $6.0 Million Private Placement Priced At a Premium to the Market Price with New and Existing Institutional Investors, Management, and Board Members

Cyabra, Inc. (Nasdaq: CYAB) priced a $6.0 million private placement to sell 13,818,770 shares plus Series A and Series B warrants at $0.435 per share. Series A warrants exercise at $0.50 and expire five years; Series B exercise at $0.45 and expire 12 months, both subject to stockholder approval. Preferred shares will convert to common or equivalents, pending approval.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$CVXMedAI 8/10

Chevron (CVX) Doubles Down on Venezuela with a $7 Billion Oil Bet

Chevron (CVX) plans to invest $7 billion in Venezuela over five years to double oil production to 600,000 barrels per day, adding areas in the Orinoco Belt to its joint venture with PDVSA. The move leverages Chevron's existing presence and aims for low-cost growth, despite political and regulatory risks. Venezuela holds the world's largest crude oil reserves but faces infrastructure challenges.

$LULULow

Lululemon Founder's $6.1B Fortune Thrown Into Chaos as He Divorces Wife of 20 Years With No Prenup

Lululemon founder Chip Wilson, estimated to have a $6.1B fortune, is divorcing his wife of 20 years without a prenuptial agreement. Under British Columbia law, their assets, including Wilson's 8.6% stake in Lululemon and 18% stake in Amer Sports, could be divided equally. The divorce may impact Lululemon's share price and market volatility, with analysts watching closely.